500 Bibliografia [1] Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000 Jan;8(1):33-9. [2] Sonis ST “Mucositis: The impact, biology and therapeutic opportunities of oral mucositis”. Oral Oncol. 2009 Dec;45(12):101520. [3] Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001 Apr 15;19(8):2201-5. [4] Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer. 2007 May;15(5):491-6. [5] Filicko J, Lazarus HM, Flomenberg N. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant. 2003 Jan;31(1):1-10. Review. [6] Bhatt V, Vendrell N, Nau K, Crumb D, Roy V. Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation. J Oncol Pharm Pract. 2010 Sep;16(3):195-204. doi: 10.1177/1078155209348721. [7] Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V, Costazza G, Mega A, Matozzo V, Berni M, Alberani F, Banfi MM, Martinelli L, Munaron S, Orlando L, Lubiato L, Leanza S, Guerrato R, Rossetti A, Messina M, Barzetti L, Satta G, Dimonte V. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT--results of a multicentre study. Bone Marrow Transplant. 2011 May;46(5):727-32. doi: 10.1038/bmt.2010.184. Epub 2010 Sep 6. [8] Sonis ST “The pathobiology of mucositis”. Nat Rev Cancer. 2004 Apr;4(4):277-84. Review [9] Quinn B, Potting CM, Stone R, Blijlevens NM, Fliedner M, Margulies A, Sharp L. Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer. 2008 Jan;44(1):61-72. Epub 2007 Nov 7. Review. [10] Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE. Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer. 2005 Jan;13(1):32-41. Epub 2004 Nov 12. [11] Fulton JS, Middleton GJ, McPhail JT. Management of oral complications. Semin Oncol Nurs. 2002 Feb;18(1):28-35. [12] McGuire DB, Johnson J, Migliorati C. Promulgation of guideliRingraziamenti Un sentito ringraziamento all’Unità di Ricerca ed EBP delle Professioni Sanitarie dell’AUSL-IRCCS di Reggio Emilia che ha sempre fatto della mucosite orale un ambito di interesse primario per la ricerca infermieristica. nes for mucositis management: educating health care professionals and patients. Support Care Cancer. 2006 Jun;14(6):548-57. Epub 2006 Apr 29. [13] FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration manual, Eight Edition (Version 8.1). December 14, 2021. Available at: https://www.ebmt.org/8th-edition-fact-jacie-standards. Accessed: 10 August 2022. [14] Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020 Oct 1;126(19):4423-4431. doi: 10.1002/cncr.33100. [15] Clarkson JE, Worthington HV, Furness S, McCabe M, Khalid T, Meyer S. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2010 Aug 4; (8):CD001973. doi: 10.1002/14651858.CD001973.pub4. Review. [16] Peterson DE, Boers-Doets CB, Bensadoun RJ, Herrstedt J; ESMO Guidelines Committee. Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2015 Sep;26 Suppl 5:v139-51. doi: 10.1093/annonc/mdv202. [17] Sadler GR, Oberlee-Edwards L, Farooqi A, Hryniuk WM (2000) Oral sequelae of chemotherapy: an important teaching opportunity for oncology health care providers and their patients. Support Care Cancer 8:209–214 [18] Arnold R et al (1991) Educating for a change. Doris Marshall Institute for Education and Action, Toronto (Ontario, Canada), Between the Lines,Toronto, Ontario, Canada [19] Cooley ME, Moriarty H, Berger MS, SElm-Orr D, Coyle B, Short T (1995) Patient literacy and the readability of written cancer educational materials. Oncol Nurs Forum 22:1345–1351 [20] Doak LG, Doak CC, Meade CD (1996) Strategies to improve cancer education materials. Oncol Nurs Forum 23:1305–1312 [21] European Oral Care in Cancer group (EOCC): oral care guidance and support. First Edition. 2017. Available at www.eocc.co.uk . Accessed: 12 August 2020 [22] Kuten-Shorrer M, Woo SB, Treister NS. Oral graft-versus-host disease. Dent Clin North Am. 2014 Apr;58(2):351-68. doi: 10.1016/j. cden.2013.12.007. Review. [23] Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, Fall-Dickson JM, Johansen J, Ameringer S, Kataoka T, Weikel D, Eilers J, Ranna V, Vaddi A, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology
RkJQdWJsaXNoZXIy ODUzNzk5